Ingredient glossary
Tazarotene
On your shelf ✓What Tazarotene does for your skin, who it suits, and what to watch for.
INCI: Tazarotene
In short: Tazarotene delivers anti acne and anti-aging support, earns its place for acne prone and photoaged, and the evidence behind it is strong. One thing to know: not for pregnancy or breastfeeding; can irritate, ease in slowly.
- What it does
- Anti acne, anti aging
- Best for
- Acne prone, photoaged
- Watch out
- Not for pregnancy or breastfeeding; can irritate, ease in slowly
- Evidence
- Strong
- How long
- 2–4 weeks
The molecule
The Glow take
One of the ingredients I trust most.
When your goal is calming breakouts and congestion, Tazarotene delivers, and the research properly backs it up. Skip it while you are pregnant or breastfeeding, and the rest of the time bring it in slowly.
— Maya
What it does
- anti acne
- anti aging
- texture
Tazarotene scores -2 on barrier support. It is one of only 8 ingredients in our glossary that go below zero there. A negative score means it asks something of the barrier rather than giving something back, which is why it needs introducing slowly and pairing with ingredients that do support the barrier. It is not a reason to avoid it: the same evidence that shows the irritation also shows the long-term gains. See where it sits against all 291 of them →
strong evidenceThe randomised vehicle-controlled trials are real but sponsor-run, and they land on 0.1%, not across the whole 0.05-0.1% band: for acne, 0.1% gel succeeded in 68% of patients versus 40% on vehicle over 12 weeks, while 0.05% reached only 51% and was never licensed for acne at all. The photoaging licence is narrower than the word suggests - 0.1% cream is approved only as an adjunct that mitigates fine wrinkling and mottled pigment alongside sun avoidance, and the label itself says it does not reverse photoaging. Irritation is the norm rather than a risk at that strength (desquamation 40%, erythema 34%, burning 26%, against 3%, 3% and under 1% on vehicle), and every strength is prescription-only.
On a label: works best above 0.05%.
Who it's for, and who should skip it
Tends to suit
- acne prone
- photoaged
Approach with care
- pregnancy
- breastfeeding
- very sensitive
- Clogs poresLow
- Irritation riskHigh
How it fits each skin type
- DryNeutral
- CombinationNeutral
- OilyNeutral
- SensitiveTake care
Often chosen for acne prone, photoaged. Take extra care if any of these apply to you: pregnancy, breastfeeding.
Worried about purging? Here is what the trials actually measured →
Where it fits in your routine
Increases sun sensitivity while you are using it, so sunscreen matters more than usual.
Retinoid: the approved labelling carries an explicit photosensitivity and burning-susceptibility warning directing sun avoidance and sunscreen use, and the photodamage indication is licensed only for patients using a comprehensive sun-avoidance programme.
FDA-approved tazarotene (Tazorac/Avage) labelling, photosensitivity warning and sun-avoidance adjunct indication
Give it two to four weeks — that is when the change first became measurable.
What was measured, and in whom
Measured on: noninflammatory and total lesion counts, investigator-counted against vehicle.
The 12-week vehicle-controlled gel trial reports its own onset: tazarotene 0.1% gel beat vehicle on noninflammatory and total lesion counts at every follow-up visit, and the sibling tazarotene acne programmes schedule those visits at weeks 2, 4, 8 and 12 (foam) or 4, 8 and 12 (cream), so the first separation falls at two to four weeks. Two things are genuinely slower and must not be collapsed into this number. Inflammatory lesion counts separated from vehicle only at week 12, so a reader with papules and pustules rather than comedones waits the full course. The 12-week treatment-success figure the row previously quoted (68% versus 40% on vehicle) is an endpoint statistic, not a wait. The bucket describes 0.1%: 0.05% gel reached vehicle-separation on noninflammatory and total counts only at weeks 8 and 12, reached 51% success, and was never licensed for acne. Photoageing is a separate and far slower indication - 0.1% cream is approved only as an adjunct for fine wrinkling and mottled pigment on 24-week trials, and the label says it does not reverse photoageing. Irritation is the norm at this strength and peaks in the same first weeks the benefit appears, so early flaking and erythema are not the result.
PMID:10388959 - Shalita AR, Chalker DK, Griffith RF, et al. Tazarotene gel is safe and effective in the treatment of acne vulgaris: a multicenter, double-blind, vehicle-controlled study. Cutis 1999;63(6):349-54 (the 'all follow-up visits' statement). PMID:15639698 - Shalita AR, Berson DS, Thiboutot DM, et al. Clin Ther 2004;26(11):1865-73 (0.1% cream pooled trials, assessments at weeks 0, 4, 8, 12). PMID:11735710 - Kang S, Leyden JJ, Lowe NJ, et al. Arch Dermatol 2001;137(12):1597-604 (24-week photodamage programme). All sponsor-run.
Plays well with
- ceramides
- niacinamide
- panthenol
Tazarotene, answered
Is Tazarotene safe during pregnancy?
No. Tazarotene is best avoided during pregnancy and breastfeeding. If you are pregnant or trying, leave this one out and ask your doctor about a safe alternative.
Who should avoid Tazarotene?
Approach Tazarotene with care if any of these apply to you: pregnancy, breastfeeding, and very sensitive. Its irritation risk is high, so introduce it slowly and patch test first.
What concentration of Tazarotene actually works?
Research tends to show Tazarotene starts pulling its weight above 0.05%. If a brand prints the percentage, that is the number to look for.
During pregnancy
Leave Tazarotene out while you are pregnant or breastfeeding. It sits on the list of ingredients usually held back during this time.
When in doubt, check with your doctor or midwife. They outrank any website, including this one.When it is worth booking →
This, for every label you own
One ingredient is easy. A full label is where it gets confusing. The Ingredient Decoder reads any product and tells you the honest truth, ingredient by ingredient.
Sources & how we reviewed this
- PMID 10388959abstract only, the full text is paywalled
- PMID 11735710abstract only, the full text is paywalled
- PMID 18488880read in full
- PMID 39440650read in full
- PMID 38733511read in full